RNC Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $56.9M | Buy |
248,998
+2,160
| +0.9% | +$492K | 2.59% | 14 |
|
|
2025
Q3 | $57.2M | Sell |
246,838
-1,262
| -0.5% | -$257K | 2.63% | 13 |
|
|
2025
Q2 | $46.1M | Buy |
248,100
+33
| +0% | +$6.13K | 2.23% | 17 |
|
|
2025
Q1 | $52M | Sell |
248,067
-3,361
| -1% | -$653K | 2.65% | 11 |
|
|
2024
Q4 | $44.7M | Sell |
251,428
-105,332
| -30% | -$19.4M | 2.39% | 16 |
|
|
2024
Q3 | $61.2M | Hold |
356,760
| – | – | 3.39% | 3 |
|
|
2024
Q2 | $61.2M | Buy |
356,760
+14,553
| +4% | +$2.41M | 3.39% | 3 |
|
|
2024
Q1 | $62.3M | Sell |
342,207
-42,562
| -11% | -$7.34M | 3.55% | 3 |
|
|
2023
Q4 | $59.6M | Buy |
384,769
+154
| +0% | +$22.5K | 3.57% | 4 |
|
|
2023
Q3 | $57.3M | Sell |
384,615
-20,322
| -5% | -$2.98M | 3.56% | 4 |
|
|
2023
Q2 | $54.6M | Sell |
404,937
-5,438
| -1% | -$797K | 3.02% | 8 |
|
|
2023
Q1 | $65.4M | Sell |
410,375
-17,312
| -4% | -$2.65M | 3.69% | 4 |
|
|
2022
Q4 | $69.1M | Buy |
427,687
+2,139
| +0.5% | +$328K | 3.87% | 3 |
|
|
2022
Q3 | $57.1M | Buy |
425,548
+3,209
| +0.8% | +$460K | 3.58% | 4 |
|
|
2022
Q2 | $64.7M | Buy |
422,339
+7,373
| +2% | +$1.13M | 3.68% | 2 |
|
|
2022
Q1 | $67.3M | Sell |
414,966
-173,907
| -30% | -$25.3M | 3.41% | 5 |
|
|
2021
Q4 | $79.7M | Sell |
588,873
-2,826
| -0.5% | -$334K | 3.95% | 2 |
|
|
2021
Q3 | $63.8M | Buy |
591,699
+5,726
| +1% | +$654K | 3.39% | 5 |
|
|
2021
Q2 | $66M | Buy |
585,973
+71,969
| +14% | +$8.11M | 3.49% | 5 |
|
|
2021
Q1 | $55.6M | Sell |
514,004
-9,560
| -2% | -$1.02M | 3.14% | 5 |
|
|
2020
Q4 | $56.1M | Sell |
523,564
-18,711
| -3% | -$1.8M | 3.48% | 4 |
|
|
2020
Q3 | $47.5M | Sell |
542,275
-37,772
| -7% | -$3.56M | 3.37% | 2 |
|
|
2020
Q2 | $56.9M | Buy |
580,047
+8,370
| +1% | +$737K | 4.11% | 1 |
|
|
2020
Q1 | $43.6M | Sell |
571,677
-100,790
| -15% | -$8.58M | 3.72% | 1 |
|
|
2019
Q4 | $59.5M | Buy |
672,467
+14,333
| +2% | +$1.19M | 3.76% | 2 |
|
|
2019
Q3 | $49.8M | Sell |
658,134
-25,649
| -4% | -$1.76M | 3.54% | 3 |
|
|
2019
Q2 | $49.7M | Buy |
683,783
+195,310
| +40% | +$15.4M | 3.46% | 1 |
|
|
2019
Q1 | $39.4M | Buy |
488,473
+305
| +0.1% | +$25K | 2.74% | 13 |
|
|
2018
Q4 | $45M | Buy |
488,168
+5,728
| +1% | +$504K | 3.4% | 5 |
|
|
2018
Q3 | $45.6M | Buy |
482,440
+4,132
| +0.9% | +$392K | 3.01% | 10 |
|
|
2018
Q2 | $44.3M | Buy |
478,308
+10,370
| +2% | +$1.01M | 3.12% | 9 |
|
|
2018
Q1 | $44.3M | Buy |
467,938
+752
| +0.2% | +$82.6K | 3.27% | 7 |
|
|
2017
Q4 | $45.2M | Sell |
467,186
-2,229
| -0.5% | -$210K | 3.13% | 8 |
|
|
2017
Q3 | $41.7M | Sell |
469,415
-231,911
| -33% | -$17.7M | 3.14% | 8 |
|
|
2017
Q2 | $50.9M | Buy |
701,326
+17,865
| +3% | +$1.2M | 3.94% | 1 |
|
|
2017
Q1 | $44.5M | Buy |
683,461
+28,722
| +4% | +$1.81M | 3.55% | 2 |
|
|
2016
Q4 | $41M | Buy |
654,739
+16,403
| +3% | +$1M | 3.39% | 3 |
|
|
2016
Q3 | $40.3M | Buy |
638,336
+17,996
| +3% | +$1.17M | 3.58% | 1 |
|
|
2016
Q2 | $38.4M | Buy |
620,340
+7,057
| +1% | +$430K | 3.59% | 2 |
|
|
2016
Q1 | $35M | Buy |
613,283
+185,402
| +43% | +$10.3M | 3.46% | 5 |
|
|
2015
Q4 | $25.3M | Sell |
427,881
-316,649
| -43% | -$18.2M | 2.54% | 12 |
|
|
2015
Q3 | $40.5M | Sell |
744,530
-13,740
| -2% | -$894K | 3.9% | 4 |
|
|
2015
Q2 | $50.9M | Buy |
758,270
+16,045
| +2% | +$1.05M | 4.34% | 3 |
|
|
2015
Q1 | $43.5M | Buy |
742,225
+731,230
| +6,651% | +$44.2M | 3.65% | 4 |
|
|
2014
Q4 | $720K | Buy |
10,995
+46
| +0.4% | +$2.9K | 0.06% | 78 |
|
|
2014
Q3 | $632K | Buy |
10,949
+54
| +0.5% | +$3K | 0.05% | 75 |
|
|
2014
Q2 | $615K | Sell |
10,895
-2,000
| -16% | -$105K | 0.05% | 78 |
|
|
2014
Q1 | $663K | Hold |
12,895
| – | – | 0.06% | 76 |
|
|
2013
Q4 | $681K | Sell |
12,895
-195
| -1% | -$9.58K | 0.06% | 75 |
|
|
2013
Q3 | $586K | Sell |
13,090
-1,150
| -8% | -$51K | 0.06% | 72 |
|
|
2013
Q2 | $589K | Buy |
+14,240
| New | +$623K | 0.06% | 71 |
|
Other funds holding ABBV
RNC Capital Management's ABBV Position: Q4 2025 in Review
RNC Capital Management increased its AbbVie (ABBV) stake by 0.88% in Q4 2025, buying an estimated $492K and bringing the position to 248,998 shares worth $56.9M. The position accounts for 2.59% of the portfolio, ranked #14.
RNC Capital Management first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $79.7M in Q4 2021. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.
- RNC Capital Management held 248,998 shares of AbbVie worth $56.9M as of Q4 2025.
- RNC Capital Management bought 2,160 AbbVie shares in Q4 2025, an estimated $492K.
- AbbVie made up 2.59% of RNC Capital Management's portfolio in Q4 2025, its #14 holding.
- RNC Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- RNC Capital Management's AbbVie position peaked at $79.7M in Q4 2021.
- 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.
Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.